<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: AMLN News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=amln</link><description>Latest Financial News for Amylin Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Wed, 23 Dec 2009 23:08:19 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>UPDATE - Amylin shares drop after FDA requests new studies (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh83900_2009-12-23_23-08-19_n23169365_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/4035118461</guid><pubDate>Wed, 23 Dec 2009 23:08:19 Etc/GMT</pubDate></item><item><title>Wednesday Options Recap (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1222cj2mu/*http%3A//seekingalpha.com/article/179654-wednesday-options-recap?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3698783274</guid><pubDate>Wed, 23 Dec 2009 21:02:10 Etc/GMT</pubDate></item><item><title>Incyte Jumps 5% on Pact with Lilly (at Barrons.com)</title><link>http://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=12tcm0ia7/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/21/incyte-jumps-5-on-pact-with-lilly/?mod=yahoobarrons</link><description></description><guid isPermaLink="false">yahoo_finance/3046767644</guid><pubDate>Mon, 21 Dec 2009 14:42:43 Etc/GMT</pubDate></item><item><title>3 Reasons to Buy Dendreon Today (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12t1475gd/*http%3A//www.fool.com/investing/high-growth/2009/12/18/3-reasons-to-buy-dendreon-today.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/680562435</guid><pubDate>Fri, 18 Dec 2009 19:34:01 Etc/GMT</pubDate></item><item><title>Wall to Wall Street Coverage: Upgrades and Downgrades (Minyanville)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/minyanville/091217/20091217sharonhost_id.html?.v=2</link><description>Maybe the experts know something we don&apos;t know.</description><guid isPermaLink="false">yahoo_finance/1870606820</guid><pubDate>Thu, 17 Dec 2009 14:35:00 Etc/GMT</pubDate></item><item><title>Coverage initiated on Amylin Pharms by Jefferies &amp; Co (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=AMLN</link><description></description><guid isPermaLink="false">yahoo_finance/1480943625</guid><pubDate>Thu, 17 Dec 2009 10:39:36 Etc/GMT</pubDate></item><item><title>Amylin Impresses in Head-to-Head (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28397.html?.v=1</link><description>Exenatide once weekly is currently being reviewed by the U.S. Food and Drug Administration ; a response should be out in the first quarter of 2010.</description><guid isPermaLink="false">yahoo_finance/3914593934</guid><pubDate>Wed, 16 Dec 2009 21:54:59 Etc/GMT</pubDate></item><item><title>AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/amln8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2464908690</guid><pubDate>Tue, 15 Dec 2009 21:12:19 Etc/GMT</pubDate></item><item><title>UPDATE - Amylin reports positive data from Byetta study (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh86309_2009-12-15_15-25-50_sge5be0j8_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/1274788825</guid><pubDate>Tue, 15 Dec 2009 15:25:50 Etc/GMT</pubDate></item><item><title>Novo CEO Just Says &quot;No&quot; (at CNBC)</title><link>http://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11h7vkhqe/*http%3A//www.cnbc.com/id/34428867/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3190692456</guid><pubDate>Tue, 15 Dec 2009 14:24:27 Etc/GMT</pubDate></item><item><title>Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/la25979.html?.v=1</link><description>Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® injection taken twice daily, in patients with type 2 diabetes.</description><guid isPermaLink="false">yahoo_finance/2914875578</guid><pubDate>Tue, 15 Dec 2009 13:00:00 Etc/GMT</pubDate></item><item><title>LLY: Caris Cuts to &quot;Hold&quot; (at Barrons.com)</title><link>http://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=12i4bgq9r/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/11/lly-caris-cuts-to-hold/?mod=yahoobarrons</link><description></description><guid isPermaLink="false">yahoo_finance/1580599533</guid><pubDate>Fri, 11 Dec 2009 16:25:53 Etc/GMT</pubDate></item><item><title>[$$] Genzyme Names Director After Hedge-Fund Pressure (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12igf18ki/*http%3A//online.wsj.com/article/SB10001424052748704825504574586372262068060.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/4060445711</guid><pubDate>Thu, 10 Dec 2009 04:06:52 Etc/GMT</pubDate></item><item><title>Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091208/la22850.html?.v=1</link><description>Amylin Pharmaceuticals, Inc. will be presenting at the Deutsche Bank Biotech Boston Confab on Tuesday, December 15, 2009 at 1:35 p.m. ET / 10:35 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.</description><guid isPermaLink="false">yahoo_finance/3133857411</guid><pubDate>Tue, 8 Dec 2009 21:15:00 Etc/GMT</pubDate></item><item><title>Roche Makes Strides in Race Against Merck (at Minyanville.com)</title><link>http://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=13n318omh/*http%3A//www.minyanville.com/articles/diabetes-taspoglutide-drugs-pharma-studies-minyanville/index/a/25709/from/yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2558721165</guid><pubDate>Wed, 2 Dec 2009 17:25:00 Etc/GMT</pubDate></item><item><title>headline (at CNBC)</title><link>http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hq25c6r/*http%3A//www.cnbc.com/id/34172937/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2575445780</guid><pubDate>Mon, 30 Nov 2009 23:15:36 Etc/GMT</pubDate></item><item><title>[video] Stock Pops &amp; Drops (at CNBC)</title><link>http://us.rd.yahoo.com/finance/external/video/cnbc/rss/SIG=113mb0hsu/*http%3A//www.cnbc.com/id/15840232?play=1&amp;video=1346683427&amp;__source=yahoo%7Cheadline%7Cquote%7Cvideo%7C&amp;par=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2788234619</guid><pubDate>Mon, 30 Nov 2009 22:45:00 Etc/GMT</pubDate></item><item><title>Byetta Label Revised (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091127/27707.html?.v=1</link><description>Amylin and Eli Lilly have announced that the U.S. Food and Drug Administration has implemented label changes for Byetta which is indicated for the treatment of type II diabetes.</description><guid isPermaLink="false">yahoo_finance/3412296943</guid><pubDate>Fri, 27 Nov 2009 17:52:37 Etc/GMT</pubDate></item><item><title>A Big Upgrade for Amylin Pharmaceuticals (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=132ab9dvh/*http%3A//www.fool.com/investing/general/2009/11/25/a-big-upgrade-for-amylin-pharmaceuticals.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2800335712</guid><pubDate>Wed, 25 Nov 2009 20:20:32 Etc/GMT</pubDate></item><item><title>In Pictures: Class Of 2010--Short-Sellers (at Forbes.com)</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13r5qk4v5/*http%3A//www.forbes.com/2009/11/24/bears-stocks-investing-personal-finance-investment-guide-2-09-short-sellers_slide.html?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/1333682669</guid><pubDate>Tue, 24 Nov 2009 23:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c5.finance.sp2.yahoo.com compressed/chunked Wed Dec 23 20:55:59 PST 2009 -->
